Qianyi Lu1, Li Lu2, Wei Chen3, Peirong Lu4. 1. Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. 2. Department of Ophthalmology, Anhui Provincial Hospital, Anhui Medical University, Hefei, 230001, China. 3. Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong, 226001, China. 4. Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. lupeirong@suda.edu.cn.
Abstract
PURPOSE: To investigate the vitreous and serum levels of angiopoietin-like protein 8 (ANGPTL-8) and vascular endothelial growth factor (VEGF) in patients with proliferative diabetic retinopathy (PDR). The serum levels of these factors were also analyzed in patients with diabetes and no diabetic retinopathy (NDR) and with non-proliferative diabetic retinopathy (NPDR), to detect the possible correlation between the ANGPTL-8 levels and hyperlipidemia. METHODS: Vitreous samples were obtained from 28 patients with PDR and from 12 patients without diabetes and with idiopathic macular hole (IMH). Serum samples were also obtained from 26 patients with NDR and 22 patients with NPDR. ANGPTL-8 levels and other factors were determined using an enzyme-linked immunosorbent assay. RESULTS: The ANGPTL-8 and VEGF levels in the vitreous and serum of the patients with PDR were higher than those in the patients with IMH, and were significantly correlated. The vitreous and serum ANGPTL-8 levels were more correlated with the triglyceride and low-density lipoprotein cholesterol levels than with the high-density lipoprotein cholesterol or total cholesterol levels in the patients with PDR. CONCLUSIONS: The vitreous and serum ANGPTL-8 levels were both upregulated in patients with PDR. There was an association between the elevation in the ANGPTL-8 levels and angiogenic and hyperlipidemic factors in the patients with PDR. These results suggest that ANGPTL-8 is a potential new diagnostic marker and therapeutic target for PDR treatment.
PURPOSE: To investigate the vitreous and serum levels of angiopoietin-like protein 8 (ANGPTL-8) and vascular endothelial growth factor (VEGF) in patients with proliferative diabetic retinopathy (PDR). The serum levels of these factors were also analyzed in patients with diabetes and no diabetic retinopathy (NDR) and with non-proliferative diabetic retinopathy (NPDR), to detect the possible correlation between the ANGPTL-8 levels and hyperlipidemia. METHODS: Vitreous samples were obtained from 28 patients with PDR and from 12 patients without diabetes and with idiopathic macular hole (IMH). Serum samples were also obtained from 26 patients with NDR and 22 patients with NPDR. ANGPTL-8 levels and other factors were determined using an enzyme-linked immunosorbent assay. RESULTS: The ANGPTL-8 and VEGF levels in the vitreous and serum of the patients with PDR were higher than those in the patients with IMH, and were significantly correlated. The vitreous and serum ANGPTL-8 levels were more correlated with the triglyceride and low-density lipoprotein cholesterol levels than with the high-density lipoprotein cholesterol or total cholesterol levels in the patients with PDR. CONCLUSIONS: The vitreous and serum ANGPTL-8 levels were both upregulated in patients with PDR. There was an association between the elevation in the ANGPTL-8 levels and angiogenic and hyperlipidemic factors in the patients with PDR. These results suggest that ANGPTL-8 is a potential new diagnostic marker and therapeutic target for PDR treatment.
Authors: Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs Journal: Proc Natl Acad Sci U S A Date: 2013-09-16 Impact factor: 11.205
Authors: Hoon-Ki Sung; Kyung-Oh Doh; Joe Eun Son; Jin Gyoon Park; Yunui Bae; Soojeong Choi; Seana Mary Lunney Nelson; Rebecca Cowling; Kristina Nagy; Iacovos P Michael; Gou Young Koh; S Lee Adamson; Tony Pawson; Andras Nagy Journal: Cell Metab Date: 2013-01-08 Impact factor: 27.287
Authors: Robert L Hanson; Fatjon Leti; Darwin Tsinajinnie; Sayuko Kobes; Sobha Puppala; Joanne E Curran; Laura Almasy; Donna M Lehman; John Blangero; Ravindranath Duggirala; Johanna K DiStefano Journal: Mol Genet Metab Date: 2016-04-19 Impact factor: 4.797
Authors: Drahomira Holmannova; Lenka Borska; Ctirad Andrys; Pavel Borsky; Jan Kremlacek; Kvetoslava Hamakova; Vit Rehacek; Andrea Malkova; Tereza Svadlakova; Vladimir Palicka; Jan Krejsek; Zdenek Fiala Journal: J Immunol Res Date: 2020-05-20 Impact factor: 4.818